<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78921</article-id><article-id pub-id-type="doi">10.7554/eLife.78921</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Neutrophil-mediated fibroblast-tumor cell IL-6/STAT-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: a hybrid clinical-preclinical study</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-276646"><name><surname>de Castro Silva</surname><given-names>Iago</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276820"><name><surname>Bianchi</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276821"><name><surname>Deshpande</surname><given-names>Nilesh U</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276819"><name><surname>Sharma</surname><given-names>Prateek</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276822"><name><surname>Mehra</surname><given-names>Siddharth</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291413"><name><surname>Garrido</surname><given-names>Vanessa Tonin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291414"><name><surname>Saigh</surname><given-names>Shannon Jacqueline</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276823"><name><surname>England</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276824"><name><surname>Hosein</surname><given-names>Peter Joel</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291712"><name><surname>Kwon</surname><given-names>Deukwoo</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-276826"><name><surname>Merchant</surname><given-names>Nipun B</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-274492"><name><surname>Datta</surname><given-names>Jashodeep</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2869-1571</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Surgery</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Surgery</institution>, <institution>University of Nebraska Medical Center</institution>, <addr-line><named-content content-type="city">Omaha</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Sylvester Comprehensive Cancer Center</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution content-type="dept">Department of Pathology</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Department of Medicine</institution>, <institution>University of Miami</institution>, <addr-line><named-content content-type="city">Miami</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Public Health Sciences</institution>, <institution>The University of Texas Health Science Center at Houston</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-65212"><name><surname>Cukierman</surname><given-names>Edna</given-names></name><role>Reviewing editor</role><aff><institution>Fox Chase Cancer Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>jash.datta@med.miami.edu</email> (JD);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>09</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e78921</elocation-id><history><date date-type="received"><day>24</day><month>03</month><year>2022</year></date><date date-type="accepted"><day>13</day><month>09</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, de Castro Silva et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>de Castro Silva et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78921-v1.pdf"/><abstract><p><bold>Background:</bold> Partial/complete pathologic response following neoadjuvant chemotherapy (NAC) in pancreatic cancer (PDAC) patients undergoing pancreatectomy is associated with improved survival. We sought to determine whether neutrophil-to-lymphocyte ratio (NLR) dynamics predict pathologic response following chemotherapy in PDAC, and if manipulating NLR impacts chemosensitivity in preclinical models and uncovers potential mechanistic underpinnings underlying these effects.</p> <p><bold>Methods:</bold> Pathologic response in PDAC patients (n=94) undergoing NAC and pancreatectomy (7/2015-12/2019) was dichotomized as partial/complete or poor/absent. Bootstrap-validated multivariable models assessed associations between pre-chemotherapy NLR (%neutrophils÷%lymphocytes) or NLR dynamics during chemotherapy (ΔNLR=pre-surgery-pre-chemotherapy NLR) and pathologic response, disease-free survival (DFS), and overall survival (OS). To preclinically model effects of NLR attenuation on chemosensitivity, <italic>Ptf1a<sup>Cre/+</sup>; Kras<sup>LSL-G12D/+</sup>;Tgfbr2<sup>flox/flox</sup></italic> (PKT) mice and C57BL/6 mice orthotopically injected with <italic>Kras<sup>LSL-G12D/+</sup>;Trp53<sup>LSL-R172H/+</sup>;Pdx1<sup>Cre</sup></italic> (KPC) cells were randomized to vehicle, gemcitabine/paclitaxel alone, and NLR-attenuating anti-Ly6G with/without gemcitabine/paclitaxel treatment.</p> <p><bold>Results:</bold> In 94 PDAC patients undergoing NAC (median:4 months), pre-chemotherapy NLR (P&lt;0.001) and ΔNLR attenuation during NAC (P=0.002) were independently associated with partial/complete pathologic response. An NLR score=pre-chemotherapy NLR+ΔNLR correlated with DFS (P=0.006) and OS (P=0.002). Upon preclinical modeling, combining NLR-attenuating anti-Ly6G treatment with gemcitabine/paclitaxel-compared with gemcitabine/paclitaxel or anti-Ly6G alone-not only significantly reduced tumor burden and metastatic outgrowth, but also augmented tumor-infiltrating CD107a<sup>+</sup>-degranulating CD8<sup>+</sup> T-cells (P&lt;0.01) while dampening inflammatory cancer-associated fibroblast (CAF) polarization (P=0.006) and chemoresistant IL-6/STAT-3 signaling <italic>in vivo</italic>. Neutrophil-derived IL-1β emerged as a novel mediator of stromal inflammation, inducing inflammatory CAF polarization and CAF-tumor cell IL-6/STAT-3 signaling in e<italic>x vivo</italic> co-cultures.</p> <p><bold>Conclusions:</bold> Therapeutic strategies to mitigate neutrophil-CAF-tumor cell IL-1β/IL-6/STAT-3 signaling during NAC may improve pathologic responses and/or survival in PDAC.</p> <p><bold>Funding:</bold> Supported by KL2 career development grant by Miami CTSI under NIH Award UL1TR002736, Stanley Glaser Foundation, American College of Surgeons Franklin Martin Career Development Award, and Association for Academic Surgery Joel J. Roslyn Faculty Award (to J. Datta); NIH R01 CA161976 (to N.B. Merchant); and NCI/NIH Award P30CA240139 (to J. Datta and N.B. Merchant).</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>UL1TR002736</award-id><principal-award-recipient><name><surname>Datta</surname><given-names>Jashodeep</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005301</institution-id><institution>American College of Surgeons</institution></institution-wrap></funding-source><award-id>Franklin H. Martin Research Fellowship</award-id><principal-award-recipient><name><surname>Datta</surname><given-names>Jashodeep</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006318</institution-id><institution>Association for Academic Surgery Foundation</institution></institution-wrap></funding-source><award-id>Joel J. Roslyn Faculty Award</award-id><principal-award-recipient><name><surname>Datta</surname><given-names>Jashodeep</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006686</institution-id><institution>University of Miami</institution></institution-wrap></funding-source><award-id>Stanley Glaser Foundation Award</award-id><principal-award-recipient><name><surname>Datta</surname><given-names>Jashodeep</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>P30CA240139</award-id><principal-award-recipient><name><surname>Merchant</surname><given-names>Nipun B</given-names></name><name><surname>Datta</surname><given-names>Jashodeep</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01CA161976</award-id><principal-award-recipient><name><surname>Merchant</surname><given-names>Nipun B</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was strictly performed in agreement with all the recommendations stablished in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All animal work was performed following the approved Institutional Animal Care and Use Committee (IACUC) protocol (#21-057) of the University of Miami, and supervised by the Division of Veterinary Resources (DVR). All surgical procedures were performed under general anesthesia, analgesic drugs were administered postoperatively, and every effort was made to minimize any form of animal suffering.</p></fn><fn fn-type="other"><p>Human subjects: -Informed consent was not necessary since tissue sections were accrued previously under a cancer center-wide biospecimen protocol-Institution Review Board /PRMC/site disease group approval for this study was obtained under protocol 20200123</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Clinicodemographic data utilized in this analysis can be tracked back to individual patients (e.g., age, CA19-9 values, pathologic response score) despite deidentification. Since these comprise protected health information from human subjects, a limited deidentified dataset with only relevant data to allow reproduction of major findings are provided. All relevant source data from in vitro experiments have also been provided.</p></sec><supplementary-material><ext-link xlink:href="elife-78921-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>